β-Nicotinamide Mononucleotide (NMN)
Munguva pfupi yapfuura, kune nhau dzakanaka mumunda weNMN - mushure mekuongorora kwakasimba nekomiti yehunyanzvi yeUS Food and Drug Administration (FDA) ine chiremera sangano, iyo NMN mbishi yeShangke Biopharmaceutical (Shanghai) Co., Ltd. ku "Shangke Bio") yakatenderwa neUnited States FDA NDI mvumo inosimbisa kuti NMN yayo yakasvibirira inogona kushandiswa zviri pamutemo mukugadzira, kutengesa uye kusimudzirwa kwezvekudya zvekuwedzera muUnited States, uye inogona kuwanikwa pane mukuru weFDA. webhusaiti sechitsva chekudya chinowedzera mbishi zvinhu, nhamba 1247.
FDA NDI ndiyo inonyanya kukosha certification system mumusika weUS.Kuwana chitupa ichi hakungorevi kuti kuchengetedzeka uye mhando yezvigadzirwa zveShangke Bio zviriinozivikanwa zvikuru, asi zvakare inobatsira kuenderera mberi kwakamira kusimudzira kweNMN indasitiri mukufamba kwenguva.
| Chemical Name | β-Nicotinamide Mononucleotide |
| Mashoko anoreva zvakafanana | NICOTINAMIDE-1-IUM-1-BETA-D-RIBOFURANOSIDE 5'-PHOSPHATE |
| Nhamba yeCAS | 1094-61-7 |
| Molecular Weight | 334.22 |
| Molecular Formula | C11H15N2O8P |
| EINECS 号: | 214-136-5 |
| Melting point | 166 °C(Zvita.) |
| kuchengetedza temp. | -20°C |
| solubility | DMSO (Zvishoma, Kupisa), Methanol (Zvishoma), Mvura (Zvishoma) |
| form | Solid |
| color | Muchena kusvika kuYero |
| Merck | 13,6697 |
| BRN | 3570187 |
| Kugadzikana: | Very Hygroscopic |
| InChIKey | DAYLJWODMCOQEW-TURQNECASA-N |
| Test Item | Zvinotsanangurwa |
| Chitarisiko | Ichena kusvika kunze-chena crystalline poda |
| Sodium content | ≤1% |
| pH kukosha (100mg/ml) | 2.0~4.0 |
| Kuchena | ≥99.0% |
| Mvura yemvura | ≤1% |
| Heavy metals | <10ppm |
| Arsenic | <0.5ppm |
| Tungamira | <0.5ppm |
| Mercury | <0.1ppm |
| Cadmium | <0.5ppm |
| Solvent yakasara | Ethanol≤1000ppm |
| Total Aerobic Microbial Count | <750cfu/g |
| Yeast & Mold | <25cfu/g |
| Total coliform | ≤0.92MPN/g |
| E. Coli | Negative |
| Salmonella | Negative |
| Staph.Aureus | Negative |
| Assay (pane anhydrous basis) | ≥99.0% |
| Sieving rate | ≥95% |
| Bulk density | Report for information |
Package:Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakasimba, isingachinji chiedza, kuitira kuchengetedza kwenguva refu chengetedza pa2 ~ 8°C kana pasi.
Nicotinamide Mononucleotide (NMN) ishanduro yevhitamini B3 inova 1 nhanho inotangira kuNAD+ (Nicotinamide Adenine Dinucleotide).NMN ndiyo yekutanga cellular NAD + inodzoreredza kuratidzwa inoshanda kudzoreredza maseru mu vivo.
Nicotinamide Adenine Dinucleotide (NAD) ndeimwe yeakakosha uye anonakidza mamorekuru mumuviri.Inodiwa kune anopfuura mazana mashanu ekuita enzymatic uye inoita mabasa akakosha mukutonga kweanenge ese makuru ezvipenyu maitiro (Ansari naRaghava, 2010).Kupfuura zvese, zvinogona kutibvumira kurarama hupenyu hune hutano uye hwakareba.
Nicotinamide Adenine Dinucleotide (NAD) iripo mune yayo oxidized fomu (NAD+) kana yakaderedzwa fomu (NADH), ari akakosha cofactors ehuwandu hweoxireductases.
SyncoZyems seyekutanga kuwana FDA NDI NMN yakabvumidzwa bhizinesi rekugadzira zvinhu, inomiririra mukuru weFDA anogamuchira NMN serudzi rutsva rwezvinhu zvinogona kutanga kugamuchirwa uye kubvumidzwa kune zvekuwedzera zvekudya muUnited States.
